These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9873745)

  • 1. Synthesis of 4'-epi-iodo-4'-deoxy-daunorubicin, a potential cancer radiotherapeutic agent.
    Murali D; DeJesus OT
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3419-22. PubMed ID: 9873745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
    Ghirmai S; Mume E; Tolmachev V; Sjöberg S
    Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K; Takagi Y; Tsuchiya T
    Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
    Cheung TM; Horton D; Priebe W; Turner WR; Weckerle W
    J Antibiot (Tokyo); 1985 May; 38(5):683-6. PubMed ID: 4019314
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
    J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting anthracycline scaffold for designing DNA-targeting agents.
    Priebe W; Fokt I; Przewloka T; Chaires JB; Portugal J; Trent JO
    Methods Enzymol; 2001; 340():529-55. PubMed ID: 11494869
    [No Abstract]   [Full Text] [Related]  

  • 9. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin].
    Povarov LS; Isaeva NN
    Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
    Israel M; Airey JE; Murray RJ; Gillard JW
    J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activity of the intercalating agent 3-acetamido-5-[123/125I]iodo-6-aminoacridine.
    Kinsey BM; Fayad F; Venkateshan CN; Adelstein SJ; Kassis AI
    Int J Rad Appl Instrum B; 1990; 17(3):341-6. PubMed ID: 2341291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 7-O-[2,6-dideoxy-2-fluoro-4-O-(3-fluorotetrahydropyran-2-yl)- alpha-L-talopyranosyl]daunomycinone.
    Takagi Y; Sohtome H; Tsuchiya T; Umezawa S; Takeuchi T
    J Antibiot (Tokyo); 1992 Mar; 45(3):355-62. PubMed ID: 1577663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and antitumor activities of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Tsuchiya T; Takagi Y; Ok K; Umezawa S; Takeuchi T; Wako N; Umezawa H
    J Antibiot (Tokyo); 1986 May; 39(5):731-3. PubMed ID: 3733524
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy.
    Ickenstein LM; Edwards K; Sjöberg S; Carlsson J; Gedda L
    Nucl Med Biol; 2006 Aug; 33(6):773-83. PubMed ID: 16934696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.
    Versluis AJ; Rump ET; Rensen PC; Van Berkel TJ; Bijsterbosch MK
    Pharm Res; 1998 Apr; 15(4):531-7. PubMed ID: 9587947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic anthracyclines: regiospecific total synthesis of D-ring thiophene analogues of daunomycin.
    Kita Y; Kirihara M; Sekihachi J; Okunaka R; Sasho M; Mohri S; Honda T; Akai S; Tamura Y; Shimooka K
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1836-43. PubMed ID: 2268891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
    Nakai K; Takagi Y; Ogawa S; Tsuchiya T
    Carbohydr Res; 1999 Jul; 320(1-2):8-18. PubMed ID: 10515060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.